Abstract
Cancer is characterized by the uncontrolled abnormal proliferation of cells; it can be caused due to various reasons and one of the reasons is the continued oxidative stress which in turn is responsible for the early start and development of various types of cancers. It is the second most disease that causes death. So, it has been a great concern in accurate and early-stage detection to start effective treatment as soon as possible. Oxidative stress biomarkers in cancer are important in the detection of the disease state. Hence, in recent times research on the identification of oxidative stress biomarkers is increasing very rapidly. There are different omics-based approaches available that include genomics, proteomics, and metabolomics for the identification of noninvasive and reliable biomarkers. Due to the large diversity in the oxidative stress of different diseases and conditions, it is very important to take into account when selecting the correct biomarker. The recent advances in various mass spectrometry-based analytical platforms are helping in the detection of all biomarkers even if they are in very low concentration in the clinical sample. However, liquid chromatography coupled with mass spectrometry (LC-MS) and capillary electrophoresis coupled with mass spectrometry (CE-MS) are showing the leading applicability in the identification of protein- and metabolite-related biomarkers. This chapter provides detailed information on different biomarkers involved in various types of cancers, different omics approaches, and the advanced analytical platforms used for the identification of those biomarkers. It also provides detailed information on challenges being faced during the identification of biomarkers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akçay T, Saygılı I, Andican G, Yalçın V. Increased formation of 8-hydroxy-2’-deoxyguanosine in peripheral blood leukocytes in bladder cancer. Urol Int. 2003;71(3):271–4.
Aldini G, Yeum K-J, Niki E, Russell RM (2011) Biomarkers for antioxidant defense and oxidative damage: principles and practical applications. Blackwell Publishing Ltd., Hoboken, New Jersey, United States
Allgrove JE, Gomes E, Hough J, Gleeson M (2008) Effects of exercise intensity on salivary antimicrobial proteins and markers of stress in active men. J Sports Sci 26(6):653–661
Amano T, Chano T, Isono T, Kimura F, Kushima R, Murakami T (2019) Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers. World J Surg Oncol 17(1):24
Ayala A, Muñoz MF, Argüelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med Cell Longev 2014:360438
Bandara IA, Baltatzis M, Sanyal S, Siriwardena AK (2018) Evaluation of tumor M2-pyruvate kinase (tumor M2-PK) as a biomarker for pancreatic cancer. World J Surg Oncol 16(1):56
Barocas DA, Motley S, Cookson MS, Chang SS, Penson DF, Dai Q, Milne G, Roberts II LJ, Morrow J, Concepcion RS. Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J Urol. 2011;185(6):2102–7.
Barrera G (2012) Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012:137289
Barrera G, Pizzimenti S, Daga M, Dianzani C, Arcaro A, Cetrangolo GP, Giordano G, Cucci MA, Graf M, Gentile F (2018) Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders. Antioxidants 7(8):102
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Becker S, Kortz L, Helmschrodt C, Thiery J, Ceglarek U (2012) LC–MS-based metabolomics in the clinical laboratory. J Chromatogr B 883:68–75
Bevan RJ, Durand MF, Hickenbotham PT, Kitas GD, Patel PR, Podmore ID, Griffiths HR, Waller HL, Lunec J (2003) Validation of a novel ELISA for measurement of MDA-LDL in human plasma. Free Radic Biol Med 35(5):517–527
Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114(2):147–152
Brzozowski JS, Bond DR, Jankowski H, Goldie BJ, Burchell R, Naudin C, Smith ND, Scarlett CJ, Larsen MR, Dun MD (2018) Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion. Sci Rep 8(1):8822
Carocho M, Ferreira IC, Morales P, Soković M (2018) Antioxidants and prooxidants: effects on health and aging. Oxidative Med Cell Longev 2018:1472708
Carrola J, Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Carreira IM, Bernardo J, Gomes A, Sousa V, Carvalho L (2010) Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 10(1):221–230
Cho W (2007a) Cancer biomarker discovery: the contribution of “omics”. BIOforum Eur 11(9):35–37
Cho WC (2007b) Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6(1):25
Cho WC (2009) Role of miRNAs in lung cancer. Expert Rev Mol Diagn 9(8):773–776
Cho WC (2010) Cancer biomarkers (an overview). In: Methods of cancer diagnosis, therapy, and prognosis. Springer, Dordrecht, pp 21–40
Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A (2007) Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 25(19):2840–2846
Coon JJ, Zürbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, Frommberger M, Golovko I, Good DM, Herget-Rosenthal S (2008) CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl 2(7–8):964–973
Czerska M, Zielinski M, Gromadzinska J (2016) Isoprostanes-A novel major group of oxidative stress markers. Int J Occup Med Environ Health 29(2):179–190
Dayem AA, Choi H-Y, Kim J-H, Cho S-G (2010) Role of oxidative stress in stem, cancer, and cancer stem cells. Cancers 2(2):859–884
Di Meo S, Reed TT, Venditti P, Victor VM (2016) Role of ROS and RNS sources in physiological and pathological conditions. Oxidative Med Cell Longev 2016:1245049
Drucker E, Krapfenbauer K (2013) Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J 4(1):7
Dubrow R, Kim CS, Eldred AK. Fecal lysozyme: an unreliable marker for colorectal cancer. Am J Gastroenterol (Springer Nature). 1992;87(5):617–21.
Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G (2017) European contribution to the study of ROS: a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol 13:94–162
Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8(4):286
Fam SS, Morrow JD (2003) The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem 10(17):1723–1740
Finno CJ, Estell KE, Winfield L, Katzman S, Bordbari MH, Burns EN, Miller AD, Puschner B, Tran CK, Xu L (2018) Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy. J Vet Intern Med 32(5):1740–1747
Frank R, Hargreaves R (2003) Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2(7):566
Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, Knight AR, Taylor EL, Oettrich J, Ruskovska T (2015) Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal 23(14):1144–1170
Furge K, Tan M, Dykema K, Kort E, Stadler W, Yao X, Zhou M, Teh B (2007) Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling. Oncogene 26(9):1346–1350
Ganti S, Weiss RH (2011) Urine metabolomics for kidney cancer detection and biomarker discovery. In: Urologic oncology: seminars and original investigations, vol 5. Elsevier, New York, pp 551–557
Gheita TA, Kenawy SA (2014) Measurement of malondialdehyde, glutathione, and glutathione peroxidase in SLE patients. In: Systemic lupus erythematosus. Springer, Berlin, pp 193–199
Giampaolo B, Angelica M, Antonio S (2002) Chromogranin ‘A’ in normal subjects, essential hypertensives and adrenalectomized patients. Clin Endocrinol 57(1):41–50
Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3(9):e3148
Glunde K, Serkova NJ (2006) Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics 7(7):1109–1123
Gönenç A, Tokgöz D, Aslan S, Torun M (2005) Oxidative stress in relation to lipid profiles in different stages of breast cancer. Indian J Biochem Biophys 42(3):190–194
Gönenç A, Özkan Y, Torun M, Şimşek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm. 2001;26(2):141–4.
González-Díaz H, González-Díaz Y, Santana L, Ubeira FM, Uriarte E (2008) Proteomics, networks and connectivity indices. Proteomics 8(4):750–778
Gowda GN, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D (2008) Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 8(5):617–633
Grollman AP, Moriya M (1993) Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 9(7):246–249
Hajar MHS, Zulkefli S, Juwita S, Norhayati MN, Suhaila MYS, Rasool AHG, Harmy MY (2018) Metabolic, inflammatory, and oxidative stress markers in women exposed to secondhand smoke. PeerJ 6:e5758
He YD (2006) Genomic approach to biomarker identification and its recent applications. Cancer Biomark 2(3–4):103–133
Ho E, Galougahi KK, Liu C-C, Bhindi R, Figtree GA (2013) Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol 1(1):483–491
Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134(5):703–707
Huo L, Li C-W, Huang T-H, Lam YC, Xia W, Tu C, Chang W-C, Hsu JL, Lee D-F, Nie L (2014) Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells. Am J Transl Res 6(6):649
Issaq HJ, Waybright TJ, Veenstra TD (2011) Cancer biomarker discovery: opportunities and pitfalls in analytical methods. Electrophoresis 32(9):967–975
Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128(4):683–692
Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG (2007) Epigenomics in respiratory epithelium carcinogenesis: prevention and therapeutic challenges. Cancer Treat Rev 33(3):284–288
Keusch GT (2006) What do-omics mean for the science and policy of the nutritional sciences? Am J Clin Nutr 83(2):520S–522S
Kind T, Tolstikov V, Fiehn O, Weiss RH (2007) A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363(2):185–195
Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, Walborg EF Jr (1998) The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106(suppl 1):289–295
Klaunig JE, Kamendulis LM, Hocevar BA (2010) Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38(1):96–109
Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2013) The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J Physiol Pharmacol 64(4):409–421
Kruk J, Duchnik E (2014) Oxidative stress and skin diseases: possible role of physical activity. Asian Pac J Cancer Prev 15(2):561–568
Kulkarni NB, Ganu MU, Godbole SG, Deo SS (2018) Assessment of potential biomarkers of atherosclerosis in Indian patients with type 2 diabetes mellitus. Indian J Med Res 147(2):169
Kuo H-W, Chou S-Y, Hu T-W, Wu F-Y, Chen D-J. Urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) and genetic polymorphisms in breast cancer patients. Mutat Res Genet Toxicol Environ Mutagen. 2007;631(1):62–8.
Lepara Z, Lepara O, Fajkić A, Rebić D, Alić J, Spahović H. Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer. Rom J Intern Med. 2020;58(3):146–52.
Liang MH, Simard JF, Costenbader K, Dore BT, Ward M, Fortin PR, Illei GG, Manzi S, Mittleman B, Buyon J (2009) Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus. Endocr Metab Immune Disord Drug Targets 9(1):108–112
Lu X, Zhao X, Bai C, Zhao C, Lu G, Xu G (2008) LC–MS-based metabonomics analysis. J Chromatogr B 866(1–2):64–76
Lunec J, Holloway KA, Cooke MS, Faux S, Griffiths HR, Evans MD (2002) Urinary 8-oxo-2′-deoxyguanosine: redox regulation of DNA repair in vivo? Free Radic Biol Med 33(7):875–885
Matsuzawa A, Ichijo H (2008) Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta Gen Subj 1780(11):1325–1336
Milne GL, Dai Q, Roberts LJ II (2015) The isoprostanes—25 years later. Biochim Biophys Acta Mol Cell Biol Lipids 1851(4):433–445
Mischak H, Schanstra JP (2011) CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl 5(1–2):9–23
Monteiro M, Carvalho M, Bastos M, Guedes de Pinho P (2013) Metabolomics analysis for biomarker discovery: advances and challenges. Curr Med Chem 20(2):257–271
Murata M, Thanan R, Ma N, Kawanishi S (2012) Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. Biomed Res Int 2012:623019
Murugaiyan SB, Ramasamy R, Nakkeeran M, Rangdhol V, Srinivasan A, Niranjan G. Urinary 8-hydroxydeoxyguanosine as a marker of oxidative stress induced genetic toxicity in oral cancer patients. Indian J Dent Res. 2015;26(3):226.
Musiek ES, Yin H, Milne GL, Morrow JD (2005) Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 40(10):987–994
Nalla LV, Kalia K, Khairnar A (2019) Self-renewal signaling pathways in breast cancer stem cells. Int J Biochem Cell Biol 107:140–153
Negrini M, Ferracin M, Sabbioni S, Croce CM (2007) MicroRNAs in human cancer: from research to therapy. J Cell Sci 120(11):1833–1840
Nourazarian AR, Kangari P, Salmaninejad A (2014) Roles of oxidative stress in the development and progression of breast cancer. Asian Pac J Cancer Prev 15(12):4745–4751
Organization WH (2001) Biomarkers in risk assessment: validity and validation. World Health Organization, Geneva
Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS (2009) Role of nitric oxide and antioxidant enzymes in the pathogenesis of oral cancer. J Cancer Res Ther 5(4):247
Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, Tisch U, Haick H (2010) Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 103(4):542–551
Pontillo C, Filip S, Borràs DM, Mullen W, Vlahou A, Mischak H (2015) CE-MS-based proteomics in biomarker discovery and clinical application. Proteomics Clin Appl 9(3–4):322–334
Pulvirenti A, Rao D, Mcintyre CA, Gonen M, Tang LH, Klimstra DS, Fleisher M, Ramanathan LV, Reidy-Lagunes D, Allen PJ (2019) Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors. HPB (Oxford) 21(5):612–618
Qiao X-W, Qiu L, Chen Y-J, Meng C-T, Sun Z, Bai C-M, Zhao D-C, Zhang T-P, Zhao Y-P, Song Y-L. Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas. BMC Endocr Disord. 2014;14(1):1–10.
Rajcevic U, Niclou SP, Jimenez CR (2009) Proteomics strategies for target identification and biomarker discovery in cancer. Front Biosci 14(1):3292–3303
Ranjbar MRN, Luo Y, Di Poto C, Varghese RS, Ferrarini A, Zhang C, Sarhan NI, Soliman H, Tadesse MG, Ziada DH (2015) GC-MS based plasma metabolomics for identification of candidate biomarkers for hepatocellular carcinoma in Egyptian cohort. PLoS One 10(6):e0127299
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603–1616
Reymond M, Beshay M, Lippert H (2008) Proteomics in lung cancer. In: Cancer proteomics. Springer, Humana Press Inc., Totowa, New Jersey, United States, pp 139–159
Rihan M, Nalla LV, Dharavath A, Shard A, Kalia K, Khairnar A (2019) Pyruvate kinase M2: a metabolic bug in re-wiring the tumor microenvironment. Cancer Microenviron 12:1–19
Roy A, Queirolo E, Peregalli F, Mañay N, Martínez G, Kordas K (2015) Association of blood lead levels with urinary F2-8α isoprostane and 8-hydroxy-2-deoxy-guanosine concentrations in first-grade Uruguayan children. Environ Res 140:127–135
Sawicka E, Kratz EM, Szymańska B, Guzik A, Wesołowski A, Kowal P, Pawlik-Sobecka L, Piwowar A (2019) Preliminary study on selected markers of oxidative stress, inflammation and angiogenesis in patients with bladder cancer. Pathol Oncol Res 26:1–11
Serkova NJ, Niemann CU (2006) Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev Mol Diagn 6(5):717–731
Shih I-M, Wang T-L (2005) Apply innovative technologies to explore cancer genome. Curr Opin Oncol 17(1):33–38
Siddiqui I, Majid H, Abid S (2017) Update on clinical and research application of fecal biomarkers for gastrointestinal diseases. World J Gastrointest Pharmacol Ther 8(1):39
Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, Thompson DC, Vasiliou V (2013) Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med 56:89–101
Singh Z, Karthigesu IP, Singh P, Rupinder K (2014) Use of malondialdehyde as a biomarker for assessing oxidative stress in different disease pathologies: a review. Iran J Public Health 43(Supple 3):7–16
Smith K, Shepherd J, Wakil A, Kilpatrick E (2011) A comparison of methods for the measurement of 8-isoPGF2 α: a marker of oxidative stress. Ann Clin Biochem 48(2):147–154
Sordillo LM, Aitken SL (2009) Impact of oxidative stress on the health and immune function of dairy cattle. Vet Immunol Immunopathol 128(1–3):104–109
Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, LLeonart ME (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12(1):376–390
Stafforini DM, Sheller JR, Blackwell TS, Sapirstein A, Yull FE, McIntyre TM, Bonventre JV, Prescott SM, Roberts LJ (2006) Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem 281(8):4616–4623
Sullivan LB, Chandel NS (2014) Mitochondrial reactive oxygen species and cancer. Cancer Metab 2(1):17
Theodoridis G, Gika HG, Wilson ID (2008) LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. TrAC Trends Anal Chem 27(3):251–260
Theodoridis GA, Gika HG, Want EJ, Wilson ID (2012) Liquid chromatography–mass spectrometry based global metabolite profiling: a review. Anal Chim Acta 711:7–16
Tiku ML, Narla H, Jain M, Yalamanchili P (2007) Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation. Arthritis Res Ther 9(4):R76
Toyokuni S (2016) The origin and future of oxidative stress pathology: from the recognition of carcinogenesis as an iron addiction with ferroptosis-resistance to non-thermal plasma therapy. Pathol Int 66(5):245–259
Tsikas D, Rothmann S, Schneider JY, Suchy M-T, Trettin A, Modun D, Stuke N, Maassen N, Frölich JC (2016) Development, validation and biomedical applications of stable-isotope dilution GC–MS and GC–MS/MS techniques for circulating malondialdehyde (MDA) after pentafluorobenzyl bromide derivatization: MDA as a biomarker of oxidative stress and its relation to 15 (S)-8-iso-prostaglandin F2α and nitric oxide (NO). J Chromatogr B 1019:95–111
Valko M, Rhodes C, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160(1):1–40
van der Merwe DE, Oikonomopoulou K, Marshall J, Diamandis EP (2006) Mass spectrometry: uncovering the cancer proteome for diagnostics. Adv Cancer Res 96:23–50
Van Ravenzwaay B, Cunha GC-P, Leibold E, Looser R, Mellert W, Prokoudine A, Walk T, Wiemer J (2007) The use of metabolomics for the discovery of new biomarkers of effect. Toxicol Lett 172(1–2):21–28
Waris G, Ahsan H (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinogenesis 5:14
Whongsiri P, Pimratana C, Wijitsettakul U, Jindatip D, Sanpavat A, Schulz WA, Hoffmann MJ, Goering W, Boonla C (2018) LINE-1 ORF1 protein is up-regulated by reactive oxygen species and associated with bladder urothelial carcinoma progression. Cancer Genomics Proteomics 15(2):143–151
Yamakoshi T, Park S-B, Jang W-C, Kim K, Yamakoshi Y, Hirose H (2009) Relationship between salivary Chromogranin-A and stress induced by simulated monotonous driving. Med Biol Eng Comput 47(4):449
Yang Y, Koh D, Ng V, Lee C, Chan G, Dong F, Goh S, Anantharaman V, Chia S (2002) Self perceived work related stress and the relation with salivary IgA and lysozyme among emergency department nurses. Occup Environ Med 59(12):836–841
Yoshihara M, Jiang L, Akatsuka S, Suyama M, Toyokuni S (2014) Genome-wide profiling of 8-oxoguanine reveals its association with spatial positioning in nucleus. DNA Res 21(6):603–612
Zhang C, Huang Y, Long J, Yao X, Wang J, Zang S, Qu W, Wang F (2019) Serum chromogranin a for the diagnosis of gastroenteropancreatic neuroendocrine neoplasms and its association with tumour expression. Oncol Lett 17(2):1497–1504
Zürbig P, Renfrow MB, Schiffer E, Novak J, Walden M, Wittke S, Just I, Pelzing M, Neusüß C, Theodorescu D (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27(11):2111–2125
Acknowledgments
Authors are also thankful to the Science and Engineering Research Board (SERB), DST, New Delhi, India, for the financial support for this research work under Extra Mural Research Funding (EMR/2016/002098).
Competing Interests
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Gajula, S.N.R., Bale, D.N.J., Nanjappan, S.K. (2022). Analytical and Omics Approaches in the Identification of Oxidative Stress-Induced Cancer Biomarkers. In: Chakraborti, S., Ray, B.K., Roychoudhury, S. (eds) Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-15-9411-3_172
Download citation
DOI: https://doi.org/10.1007/978-981-15-9411-3_172
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-9410-6
Online ISBN: 978-981-15-9411-3
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences